Investigation of erythrocyte membrane lipid peroxidation and antioxidant defense systems of patients with coronary artery disease (CAD) documented by angiography

Clinica Chimica Acta

Volumn 244, Issue 2, 1996, Pages 173-180

  Akkuş, Idris ^a   Saǧlam, Nesrin Irmak ^a   Çaǧlayan, Osman ^a   Vural, Hüseyin ^a   Kalak, Sadinaz ^a   Saǧlam, Mustafa ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Erythrocyte; Glutathione peroxidase; Lipid peroxidation; Superoxide dismutase; Vitamin C

Indexed keywords

ASCORBIC ACID; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 18744431369     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(95)06192-4     Document Type: Article

References (38)

1. Goto Y. Lipid peroxides as a cause of vascular diseases. In:. Yagi K, ed. Lipid peroxides as a cause of vascular disease in lipid peroxides in biology and medicine. New York: Academic Press, 1982;295-303.
2. Gryglewski RJ. Prostacyklina, a miazdzyca. Wroclaw, Ossolineum, 1983.
3. Harland WA, Gilbert JD, Steel G, Brooks CJW. Lipids of human atheroma. Part 5. The occurrence of a new group of polar sterol esters in various stages of human atherosclerosis. Atherosclerosis 1971;13:239-246.
4. Yagi K. Increased lipid peroxides initiate atherogenesis. Bioassays 1984;1:58-60.
5. Plachta H, Bartnikowska E, Obara A. Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries. Clin Chim Acta 1992;211:101-112.
6. Andrews B, Burnand K, Paganda G et al. Oxidisability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis. Atherosclerosis 1995;112:77-84.
7. Wilkins GM, Leake DS. The effect of inhibitors of free radical generating-enzymes on low-density lipoprotein oxidation by macrophages. Biochim Biophys Acta 1994;1211: 69-78.
8. Carpenter KLH, Wilkins GM, Fussell B et al. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochem J 1994; 304:625-633.
9. Guemouri L, Artur Y, Herbeth B. Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991;37(11):1932-1937.
10. Shlafer M, Kane PF, Kirsh M. Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. J Thorac Cardiovasc Surg 1982;83:830-839.
11. Glavind J, Hartman S, Clemmenson J, Jessen KE, Dam H. Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta. Acta Pathol Microbiol Scand 1952;30:1-6.
12. Sawada Y, Kotake H, Hoshio A et al. Serum levels of lipids and apolipoproteins in angiographically assessed coronary artery disease in Japanese patients. J Med 1992; 23(6):433-442.
13. Jain SK, McVie R, Duett J et al. Erythrocyte membrane lipid peroxidatlon and glycosylated hemoglobin in diabetes. Diabetes 1989;38:1539-1543.
14. Stocks J, Dormandy TL. The autoxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol 1971;20:95-111.
15. Roe J, Milles M, Oesterling J et al. The determination of diketo-1-gulonic acid, dehydro-1-ascorbic acid, and 1-ascorbic acid in the same tissue extract by the 2,4-dinitro-phenylhydrazine method. J Biol Chem 1948;174:201-208.
16. Stankova L, Riddle M, Larned J et al. Plasma ascorbate concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus. Metabolism 1984; 33(4):347-353.
17. Cunningham JJ, Ellis SL, McVeigh KL et al. Reduced mononuclear leukocyte ascorbic acid content in adults with insulin-dependent diabetes mellitus consuming adequate dietary vitamin C. Metabolism 1991; 40(2):146-149.
18. Omaye ST, Turnbull JD, Sauberlich HE. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol 1979;62:3-11.
19. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989;179:8-18.
20. Flohe BL, Otting F. Superoxide dismutase assays. Methods Enzymol 1984;105:93-104.
21. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-168.
22. Forslid J, Björksten B, Hagersten K et al. Erytrocyte-mediated scavenging of reactive oxygen metabolites generated human by polymorphonuclear leukocytes during phagocytosis. Inflamation 1989;13(5):543-551.
23. Loeper J, Jacqueline G, Rozensztajn L et al. Lipid peroxidation and protective enzymes during myocardial infarction. Clin Chim Acta 1991;196:119-126.
24. Jayakumari N, Ambikakumari V, Balakrishnan KG et al. Antioxidant status in relation to free radical production during stable and unstable anginal syndromes. Atherosclerosis 1992;94:(2-3):183-190.
25. Stringer MD, Görög PG, Freeman A et al. Lipid peroxides and atherosclerosis. Br Med J 1989;298:281-284.
26. Lorrie KA, Singal PK. Increase in endogenous antioxidant enzymes protects hearts against reperfusion injury. Am Physiol Soc 1993;484-493.
27. Szczeklik A, Gryglewski RJ, Domagala B, Dworski R, Basista M. Dietary supplementation with vitamin E in hyperlipoprotinaemias: effect of plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemostasis 1985;54:425-430.
28. Szczeklik A, Gryglewski RJ, Domagala B et al. Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary heart disease. Prostaglandins 1981;22:795-805.
29. Barrowoliffe TW, Gutteridge JM, Gray E. Oxygen radicals, lipid peroxidation and the coagulation systems. Agent Actions 1987;22:347-348.
30. Gray E, Barrowoliffe TW. Inhibition of antithrombin III by lipid peroxides. Thromb Res 1985;37:241-250.
31. Esterbauer H, Rothender M, Waeg G, Striedl G, Jurgens G. Biochemical, structural and functional properties of oxidized low-density lipoproteins. Chem Res Toxicol 1990;3:77-92.
32. Palinski W, Rosenfeld ME, Yla-Herttuala S et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci 1989;86:1372-1376.
33. Steinberg D. Metabolism of lipoproteins and their role in the pathogenesis of atherosclerosis. In: Stokes J, Mancini M, eds. Atherosclerosis reviews. New York: Raven Press Ltd., 1988;18:1-23.
34. Yla-Herttuala S, Palinski W, Rosenfeld ME et al. Evidence for the presence of oxidatively modified low-density lipoprotein in atherosclerotic lesions of rabbits and man. J Clin Invest 1989;84:1086-1095.
35. Gey KF. Lipids, lipoproteins and antioxidants in cardiovascular dysfunction. Biochem Soc Trans 1990;18:1041-1045.
36. Gey KF, Puska P, Jordan P. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53:326S-334S.
37. Riemersma RA, Wood CCA, Macintyre CCA et al. Plasma concentration of vitamins A, C, E and carotene and the risk of angina pectoris. Lancet 1991;8732:1-5.
38. Akyüz F, Önder E, Erden M. Evaluation of serum magnesium, zinc, copper and ascorbic acid levels in patients with hypertension and atherosclerotic heart diseases. Turk J Med Res 1993;11(6):273-276.